Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diana Oliveira has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Anabela Borges

    LEPABE, ALiCE, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, s/n, 4200-465 Porto, Portugal; DEQB-Department of Chemical and Biological Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, s/n, 4200-465 Porto, Portugal

    6 shared publications
  • Manuel Simões

    LEPABE, ALICE, Faculty of Engineering, University of Porto

    6 shared publications
  • Maria José Saavedra

    Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Institute for Innovation, Capacity Building and Sustainability of Agri-Food Production (Inov4Agro), University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal

    3 shared publications
  • Claudia Monteiro

    I3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal

    2 shared publications
  • Fernanda Borges

    CIQUP-IMS - Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, R. Campo Alegre s/n, 4169-007 Porto, Portugal

    2 shared publications
  • Maria Cristina Lopes Martins

    I3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal

    2 shared publications

Latest Publications

  • Open Access

    Screening of Natural Molecules as Adjuvants to Topical Antibiotics to Treat Staphylococcus aureus from Diabetic Foot Ulcer Infections

    by Diana Oliveira, Anabela Borges, Maria J. Saavedra, Fernanda Borges, Manuel Simões

    Diabetic foot ulcers (DFUs) are a common result of a complex secondary complication of diabetes mellitus. More than half of DFUs become infected due to frequent colonization with Staphylococcus aureus. The use of topical antibiotics is proposed, especially in combination with natural adjuvants, to minimize the negative impacts caused by generalized use of systemic antibiotics. In this study, 13 different phytochemicals—namely chalcone, juglone, cinnamic acid, trigonelline, Furvina—and four nitrovinylfuran derivatives—guaiazulene, α-bisabolol, farnesol and nerolidol—were selected to be tested as antibiotic enhancers. After minimum inhibitory and bactericidal concentration (MIC and MBC) determination of each molecule against different strains of S. aureus, including clinical isolates from diabetic foot wounds (CECT 976, Xu212, SA 1199B, RN4220, MJMC102, MJMC109, MJMC110 and MJMC111), their potentiation effects on the antibiotics fusidic acid, mupirocin, gentamicin, oxacillin and methicillin were evaluated through the disc diffusion method. Farnesol at sub-MIC was able to restore the activity of methicillin and oxacillin on the MJMC102 and MJMC111 strains, as well as two MRSA clinical isolates, and potentiated the effect of the remaining antibiotics. The results obtained demonstrate the great potential for the topical application of phytochemicals and derivatives as antibiotic resistance modifier agents to combat multidrug resistance in bacterial wound infections.


  • Top Cited Papers
    Open Access

    Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies

    by Ana C. Afonso, Diana Oliveira, Maria José Saavedra, Anabela Borges, Manuel Simões

    Diabetic foot ulcers (DFUs) are a serious complication from diabetes mellitus, with a huge economic, social and psychological impact on the patients’ life. One of the main reasons why DFUs are so difficult to heal is related to the presence of biofilms. Biofilms promote wound inflammation and a remarkable lack of response to host defences/treatment options, which can lead to disease progression and chronicity. In fact, appropriate treatment for the elimination of these microbial communities can prevent the disease evolution and, in some cases, even avoid more serious outcomes, such as amputation or death. However, the detection of biofilm-associated DFUs is difficult due to the lack of methods for diagnostics in clinical settings. In this review, the current knowledge on the involvement of biofilms in DFUs is discussed, as well as how the surrounding environment influences biofilm formation and regulation, along with its clinical implications. A special focus is also given to biofilm-associated DFU diagnosis and therapeutic strategies. An overview on promising alternative therapeutics is provided and an algorithm considering biofilm detection and treatment is proposed.


  • Open Access

    2-(2-Methyl-2-nitrovinyl)furan but Not Furvina Interfere with Staphylococcus aureus Agr Quorum-Sensing System and Potentiate the Action of Fusidic Acid against Biofilms

    by Diana Oliveira, Anabela Borges, Reinaldo Molina Ruiz, Zenaida Rodríguez Negrín, Simona Distinto, Fernanda Borges, Manuel Simões

    Quorum sensing (QS) plays an essential role in the production of virulence factors, in biofilm formation and antimicrobial resistance. Consequently, inhibiting QS is being considered a promising target for antipathogenic/anti-virulence therapies. This study aims to screen 2-nitrovinylfuran derivatives structurally related to Furvina (a broad-spectrum antibiotic already used for therapeutic purposes) for their effects on QS and in biofilm prevention/control. Furvina and four 2-nitrovinylfuran derivatives (compounds 1–4) were tested to assess the ability to interfere with QS of Staphylococcus aureus using bioreporter strains (S. aureus ALC1742 and ALC1743). The activity of Furvina and the most promising quorum-sensing inhibitor (QSI) was evaluated in biofilm prevention and in biofilm control (combined with fusidic acid). The biofilms were further characterized in terms of biofilm mass, viability and membrane integrity. Compound 2 caused the most significant QS inhibition with reductions between 60% and 80%. Molecular docking simulations indicate that this compound interacts preferentially with the protein hydrophobic cleft in the LytTR domain of AgrA pocket. Metabolic inactivations of 40% for S. aureus ALC1742 and 20% for S. aureus ALC1743 were reached. A 24 h-old biofilm formed in the presence of the QSI increased the metabolic inactivation by fusidic acid to 80%, for both strains. The overall results highlight the effects of compound 2 as well as the potential of combining QSI with in-use antibiotics for the management of skin and soft tissues infections.


  • Open Access

    Combinatorial effects of juglone and fusidic acid in controlling Staphylococcus aureus biofilms

    by Diana Oliveira, Francisco Couto, Anabela Borges, Fernanda Borges, Manuel Simões

    Chronic skin wounds are disruptions of the skin that remain in the inflammatory state for more than one month. They affect approximately 3% of the people with more than 60 years and are mostly associated with diabetic foot, pressure ulcers, blood vessels or trauma1. Besides that, it is expected that 578 million people worldwide will suffer from the disease by 2030, that will subsequently increase the risk of developing infection and potentially result in amputation or osteomyelitis2. One of the main difficulties in the wound healing process is the fact that bacteria persist due to biofilm formation. Biofilms delay not only healing, but they also make bacteria more resistant to the antimicrobial therapy. Among the bacteria present at the wound site, Staphylococcus aureus was found to be one of the most prevalent biofilm producers3. In this sense, other alternatives to fight biofilm infections should be considered due to the resistance to the current antibiotics. One possible strategy consists of using antibiotic adjuvants to enhance the activity of current drugs and to minimize or even block resistance. For that, plants are used as a resource of such adjuvant compounds. The use of natural compounds from plants have been applied in skin wound care for millennials, generating a lot of interest from the scientific community. Indeed, not only are phytochemicals great antibiotic potentiators but they also possess numerous therapeutic properties4. Therefore, in this study, the phenolic compound juglone (5-hydroxy-1,4-naphtoquinone) was investigated, alone and combined with fusidic acid antibiotic, for its potential to eradicate pre-formed S. aureus biofilms. Although no biomass removal was observed, there was a total loss of cell culturability (about 6-log CFU/cm2 reduction) and a considerable metabolic activity reduction. Juglone reduced metabolic activity by 83% both alone and in combination with fusidic acid, which is an improvement over the 70% reduction obtained by the antibiotic. Therefore, an additive interaction of juglone when combined with fusidic acid was attained in the control of S. aureus biofilms. In addition, according with Lipinsksi’s rule of five, it was assessed that juglone possesses important molecular properties with respect to pharmacokinetics in the human body. Overall, this study reveals the great potential for the topical application of juglone as an adjuvant to the widely used fusidic acid to combat multi-drug resistant wound infections.     References: (1)         Manu, C., et al. J. Wound Care 27.3 (2018): 186–192. (2)         International Diabetes Federation. https://www.diabetesatlas.org (accessed May 27, 2020). (3)         Kadam, S., et al. Biomedicines 7.2 (2019): 35. (4)         Borges, A.; et al. Molecules 21.7 (2016): 877.   Acknowledgements: This work was financially supported by: Base Funding - UIDB/00511/2020 of the Laboratory for Process Engineering, Environment, Biotechnology and Energy – LEPABE - funded by national funds through the FCT/MCTES (PIDDAC); - PTDC/BII-BTI/30219/2017 - POCI-01-0145-FEDER-030219; POCI-01-0247-FEDER-035234; POCI-01-145-FEDER-006939, funded by FEDER funds through COMPETE2020 – Programa Operacional Competitividade e Internacionalização (POCI) and by national funds (PIDDAC) through CEECIND/01261/2017 (Anabela Borges), SFRH/BD/138217/2018 (Diana Oliveira) and SFRH/BSAB/150379/2019 (Manuel Simões).

  • Open Access

    AMP–Chitosan Coating with Bactericidal Activity in the Presence of Human Plasma Proteins

    by Cláudia Monteiro, Hélia Fernandes, Diana Oliveira, Nuno Vale, Mariana Barbosa, Paula Gomes, M. Cristina L. Martins

    Antibiotic resistance is increasing and new strategies are needed to fight infection. Advanced materials are promising tools that can be combined with innovative alternatives to conventional antibiotics to allow more targeted and efficient treatment. In this work, we explored the activity against Staphylococcus epidermidis (S. epidermidis) of the α-helical antimicrobial peptide (AMP) MSI-78(4-20) (KFLKKAKKFGKAFVKIL) when covalently bound to a chitosan coating. The AMP MSI-78(4-20) (17 mer) is an improved version of its parent MSI-78 (22 mer; commercially known as Pexiganan), a cost-effective short AMP, which was demonstrated to be as effective as MSI-78 and less toxic to eukaryotic cells. An MSI-78(4-20)–chitosan coating could be applied in several infection scenarios, ranging from bone implants to wound dressings, as chitosan possesses osteoconductive and hemostatic properties. Cysteine-modified MSI-78(4-20) was covalently immobilized onto the chitosan coating through a succinimidyl-[(N-maleimidopropionamido)-octaethyleneglycol] ester (SM(PEG)8), a heterobifuncional crosslinker, with N-hydroxysuccinimide (NHS) ester and maleimide groups, by its N- and C- termini. The MSI-78(4-20)–chitosan coating demonstrated bactericidal properties independently of the tethering site and an improved performance in the presence of plasma proteins, which mimics conditions that will be encountered in vivo. This AMP–chitosan coating has therefore great potential for applications in medical devices such as implants or even wound dressings.


  • Cecropin–Melittin Functionalized Polyurethane Surfaces Prevent Staphylococcus epidermidis Adhesion without Inducing Platelet Adhesion and Activation

    by Micaela M. Querido, Helena P. Felgueiras, Akhilesh Rai, Fabíola Costa, Claudia Monteiro, Inês Borges, Diana Oliveira, Lino Ferreira, Maria Cristina Lopes Martins

    Infections and thrombus formation are major concerns for the success of blood‐contacting medical devices. Antimicrobial coatings based on antimicrobial peptides (AMPs) are described as promising strategies to fight biomaterial‐associated infections. However, their efficiency in the presence of plasma and their effect on platelets adhesion/activation, essential for blood contact applications, is not known. In this work, the AMP cecropin–melittin (CM) is covalently immobilized onto polyurethane (PU) films envisaging a coating for intravascular catheters. Immobilization is done by dip‐coating of a layer of gold nanoparticles (Au NPs) functionalized with NH2 and COOH terminated polyethylene glycol (PEG). Surfaces characterized using scanning electron microscopy (SEM), X‐ray photoelectron spectroscopy (XPS), quartz crystal microbalance with dissipation (QCM‐D), and colorimetric assays reveal a stable and homogeneous coating distribution. CM coating significantly reduces Staphylococcus epidermidis adhesion to PU films (≈80% in PBS). Its bactericidal activity is not affected in the presence of 1% human plasma (hPlasma) proteins with 65% reduction on viable bacteria comparing to PU. Moreover, CM coating is able to prevent platelet adhesion/activation to PU films (≈95% in PBS). This effect is also observed when surfaces are precoated with hPlasma. Overall, the developed antimicrobial coating demonstrates great potential to prevent bacterial infections on PU devices without instigating platelet adhesion/activation.


  • Top Cited Papers
    Open Access

    Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases

    by Diana Oliveira, Anabela Borges, Manuel Simões

    Staphylococcus aureus is a microorganism resident in the skin and nasal membranes with a dreadful pathogenic potential to cause a variety of community and hospital-acquired infections. The frequency of these infections is increasing and their treatment is becoming more difficult. The ability of S. aureus to form biofilms and the emergence of multidrug-resistant strains are the main reasons determining the challenge in dealing with these infections. S. aureus' infectious capacity and its success as a pathogen is related to the expression of virulence factors, among which the production of a wide variety of toxins is highlighted. For this reason, a better understanding of S. aureus toxins is needed to enable the development of new strategies to reduce their production and consequently improve therapeutic approaches. This review focuses on understanding the toxin-based pathogenesis of S. aureus and their role on infectious diseases.


  • Open Access

    Biofilms and antibiotic susceptibility of multidrug-resistant bacteria from wild animals

    by Carla Dias, Anabela Borges, Diana Oliveira, Antonio Martinez-Murcia, Maria José Saavedra, Manuel Simões

    Background: The “One Health” concept recognizes that human health and animal health are interdependent and bound to the health of the ecosystem in which they (co)exist. This interconnection favors the transmission of bacteria and other infectious agents as well as the flow of genetic elements containing antibiotic resistance genes. This problem is worsened when pathogenic bacteria have the ability to establish as biofilms. Therefore, it is important to understand the characteristics and behaviour of microorganisms in both planktonic and biofilms states from the most diverse environmental niches to mitigate the emergence and dissemination of resistance.Methods: The purpose of this work was to assess the antibiotic susceptibility of four bacteria (Acinetobacterspp.,Klebsiella pneumoniae,Pseudomonas fluorescensandShewanella putrefaciens) isolated from wild animals and their ability to form biofilms. The effect of two antibiotics, imipenem (IPM) and ciprofloxacin (CIP), on biofilm removal was also assessed. Screening of resistance genetic determinants was performed by PCR. Biofilm tests were performed by a modified microtiter plate method. Bacterial surface hydrophobicity was determined by sessile drop contact angles.Results: The susceptibility profile classified the bacteria as multidrug-resistant. Three genes coding for β-lactamases were detected inK. pneumoniae(TEM, SHV, OXA-aer) and one inP. fluorescens(OXA-aer).K. pneumoniaewas the microorganism that carried more β-lactamase genes and it was the most proficient biofilm producer, whileP. fluorescensdemonstrated the highest adhesion ability. Antibiotics at their MIC, 5 × MIC and 10 × MIC were ineffective in total biofilm removal. The highest biomass reductions were found with IPM (54% at 10 × MIC) againstK. pneumoniaebiofilms and with CIP (40% at 10 × MIC) againstP. fluorescensbiofilms.Discussion: The results highlight wildlife as important host reservoirs and vectors for the spread of multidrug-resistant bacteria and genetic determinants of resistance. The ability of these bacteria to form biofilms should increase their persistence.